Subcutaneous implantable cardioverter‐defibrillator: a systematic review of comparative effectiveness and safety

Subcutaneous implantable cardioverter‐defibrillator: a systematic review of comparative effectiveness and safety

Abstract This systematic review evaluated the clinical effectiveness and safety of subcutaneous implantable cardioverter‐defibrillator (S‐ICD) in patients at an increased risk of sudden cardiac death and with an ICD indication for primary or secondary prevention. A systematic literature search was c...

Full description

Bibliographic Details
Main Authors:	Sarah Wolf, Gregor Götz, Bernhard Wernly, Claudia Wild
Format:	Article
Language:	English
Published:	Wiley 2023-04-01
Series:	ESC Heart Failure
Subjects:	Implantable cardioverter‐defibrillator ICD Subcutaneous Transvenous Sudden cardiac death Evidence‐based medicine
Online Access:	https://doi.org/10.1002/ehf2.14249

Similar Items

Impairment of Quality of Life in Patients with Implanted Subcutaneous Cardioverter Defibrillator (S-ICD) Compared to Implanted Transvenous Cardioverter Defibrillator Therapy
by: Thienel M, et al.
Published: (2022-11-01)

Clinical outcomes of subcutaneous vs. transvenous implantable defibrillator therapy in a polymorbid patient cohort
by: Badder Kattih, et al.
Published: (2022-10-01)

Subcutaneous implantable cardioverter defibrillator: Where do we stand?
by: Arindam Pande, et al.
Published: (2016-01-01)

Subcutaneous implantable cardioverter-defibrillator (SICD) for sudden cardiac death - A case series
by: Viveka Kumar, et al.
Published: (2022-04-01)

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
by: Temirkhan Begisbayev, et al.
Published: (2022-05-01)

Intraoperative Defibrillation Testing of Subcutaneous Implantable Cardioverter‐Defibrillator Systems—A Simple Issue?
by: Gerrit Frommeyer, et al.
Published: (2016-03-01)

Subcutaneous implantable cardioverter defibrillator in complex adult congenital heart disease. Results from the S-ICD “Monaldi Care” registry
by: Berardo Sarubbi, et al.
Published: (2021-05-01)

Subcutaneous Implantable Cardioverter Defibrillator: A Contemporary Overview
by: Fabrizio Guarracini, et al.
Published: (2023-07-01)

Comparison of Preoperative ECG Screening and Device-Based Vector Analysis in Patients Receiving a Subcutaneous Implantable Cardioverter-Defibrillator
by: Szymon Budrejko, et al.
Published: (2023-12-01)

Patient characteristics and in‐hospital complications of subcutaneous implantable cardioverter‐defibrillator for Brugada syndrome in Japan
by: Iwanari Kawamura, et al.
Published: (2019-12-01)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
by: Krishnakumar Nair, et al.
Published: (2014-07-01)

Evaluation of subcutaneous implantable cardioverter-defibrillator performance in patients with ion channelopathies from the EFFORTLESS cohort and comparison with a meta-analysis of transvenous ICD outcomes
by: Pier D. Lambiase, MBChB, PhD, FHRS, et al.
Published: (2020-12-01)

Safety and Tolerability of Implanted Subcutaneous Cardioverter-Defibrillator Systems
by: A. V. Vereshchagina, et al.
Published: (2022-09-01)

Case report: Removal of a subcutaneous implantable cardiac defibrillator in a pediatric patient with hypertrophic cardiomyopathy after a septal myectomy. Insights on current indications of type of ICD in children with hypertrophic cardiomyopathy and left ventricular tract obstruction
by: Paola Dolader, et al.
Published: (2022-09-01)

“Carryover phenomenon” in subcutaneous implantable cardioverter‐defibrillator: Residual energy caused early shock to subsequent ventricular tachycardia
by: Yasunobu Yamagishi, et al.
Published: (2022-06-01)

Implantable cardioverter defibrillators: Uses, abuses, gains and complications
by: Weiwei Li, et al.
Published: (2017-04-01)

The subcutaneous implantable cardioverter defibrillator in daily clinical practice
by: Tardu Özkartal, et al.
Published: (2017-10-01)

Subcutaneous cardioverter-defibrillator, patient selection, implantation, postoperative management in the Krasnoyarsk
by: A. V. Prokopenko, et al.
Published: (2022-09-01)

Outcomes during and after the use of the wearable cardioverter-defibrillator in a tertiary-care and a regional hospital in Switzerland
by: Boldizsar Kovacs, et al.
Published: (2019-11-01)

Patient Activity and Survival Following Implantable Cardioverter‐Defibrillator Implantation: The ALTITUDE Activity Study
by: Daniel B. Kramer, et al.
Published: (2015-05-01)

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS ARE THE MAIN MODE FOR SUDDEN CARDIAC DEATH PREVENTION
by: L. A. Bokeria, et al.
Published: (2019-02-01)

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS ARE THE MAIN MODE FOR SUDDEN CARDIAC DEATH PREVENTION
by: L. A. Bokeria, et al.
Published: (2019-02-01)

Managing cross talk between a subcutaneous implantable cardioverter-defibrillator and a dual-chamber unipolar pacemaker system
by: Konstantinos Kossidas, MD, FHRS, et al.
Published: (2017-12-01)

A novel cause of inappropriate subcutaneous implantable cardioverter-defibrillator therapies after a generator change
by: Timothy M. Markman, MD, et al.
Published: (2021-08-01)

S-ICD Implantation "Tips and Tricks"
by: Szymon Budrejko, et al.
Published: (2023-07-01)

Usefulness of the MAGGIC Score in Predicting the Competing Risk of Non-Sudden Death in Heart Failure Patients Receiving an Implantable Cardioverter-Defibrillator: A Sub-Analysis of the OBSERVO-ICD Registry
by: Marco Canepa, et al.
Published: (2021-12-01)

Ventricular tachycardia detection with the subcutaneous implantable cardioverter-defibrillator: Tracing the cause of an absent tracing
by: Fadi Mansour, MD, et al.
Published: (2020-02-01)

Under-Utilization of Implantable Cardioverter Defibrillators in Patients with Heart Failure - The Current State of Sudden Cardiac Death Prophylaxis
by: Jayasree Pillarisetti, MD, et al.
Published: (2015-01-01)

Subcutaneous Implantable Cardioverter Defibrillator: Early Experience
by: Fernando Sérgio Oliva Souza, et al.

Cost-effectiveness and budget impact analyses of using implantable cardioverter-defibrillators in the Russian Federation
by: T. O. Bessonova, et al.
Published: (2022-04-01)

Fibrous encapsulation of defibrillation electrode and elevated high-voltage impedance in patients with a subcutaneous implantable cardioverter-defibrillator
by: Jian-Ming Li, MD, PhD, FHRS, et al.
Published: (2020-03-01)

Outcomes in Brugada Syndrome Patients With Implantable Cardioverter-Defibrillators: Insights From the SGLT2 Registry
by: Sharen Lee, et al.
Published: (2020-03-01)

Extended follow‐up after wearable cardioverter‐defibrillator period: the PROLONG‐II study
by: Johanna Mueller‐Leisse, et al.
Published: (2021-12-01)

Eligibility for subcutaneous implantable cardioverter‐defibrillator in adults with congenital heart disease
by: Christos Zormpas, et al.
Published: (2021-04-01)

Use of the wearable cardioverter-defibrillator – the Swiss experience
by: Boldizsar Kovacs, et al.
Published: (2020-09-01)

Inappropriate shocks by subcutaneous implantable cardioverter-defibrillator due to T-wave oversensing in hyperkalemia leading to ventricular fibrillation
by: Omid Kiamanesh, MD, et al.
Published: (2015-07-01)

Analysis of electrotherapy of cardioverter defibrillators implanted for the primary prevention of sudden cardiac death
by: V. K. Lebedeva, et al.
Published: (2019-08-01)

Comparative Effectiveness of Primary Prevention Implantable Cardioverter‐Defibrillators in Older Heart Failure Patients With Diabetes Mellitus
by: Abhinav Sharma, et al.
Published: (2020-06-01)

Sudden Cardiac Death Risk over Time in HCM Patients with Implantable Cardioverter-Defibrillator
by: Mariusz Klopotowski, et al.
Published: (2022-03-01)

Shoulder Joint Dislocation as an Unusual Complication of Defibrillation Threshold Testing Following Subcutaneous Implantable Cardioverter-Defibrillator Implantation
by: Amit Noheria, MBBS, SM, et al.
Published: (2014-11-01)